Skip to main content
. 2018 Dec 26;2(24):3648–3652. doi: 10.1182/bloodadvances.2018018614

Table 3.

Overall toxicities reported on randomized clinical trials

Toxicity ENESTnd DASISION BFORE
Imatinib 400 mg daily Nilotinib 400 mg twice daily Imatinib 400 mg daily Dasatinib 100 mg daily Imatinib 400 mg daily Bosutinib 400 mg daily
Grade 3 to 4 AE, % 59 72 NR NR 43 56
Serious AE, % 25 33 NR NR NR NR
AE leading to discontinuation, % 14 20 7 16 11 14

NR, not reported.